Japan Seeks Lead In International Standards For Regenerative Medicine
This article was originally published in PharmAsia News
Executive Summary
Japan is in a rush to draw safety standards for commercialization of regenerative medicine to fill a void in the current international standards that cover all other types of drugs for humans.